A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome.

MLA

Lloyd, A., et al. “A Double-Blind, Placebo-Controlled Trial of Intravenous Immunoglobulin Therapy in Patients with Chronic Fatigue Syndrome.” The American Journal of Medicine, vol. 89, no. 5, Nov. 1990, pp. 561–68. EBSCOhost, https://doi.org/10.1016/0002-9343(90)90173-b.

APA

Lloyd, A., Hickie, I., Wakefield, D., Boughton, C., & Dwyer, J. (1990). A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. The American Journal of Medicine, 89(5), 561–568. https://doi.org/10.1016/0002-9343(90)90173-b

Chicago

Lloyd, A, I Hickie, D Wakefield, C Boughton, and J Dwyer. 1990. “A Double-Blind, Placebo-Controlled Trial of Intravenous Immunoglobulin Therapy in Patients with Chronic Fatigue Syndrome.” The American Journal of Medicine 89 (5): 561–68. doi:10.1016/0002-9343(90)90173-b.